Intervention
Sham Stimulation
ClinicalTrials.gov intervention label
Clinical trials
17 shownConsideRAte Study - Splenic Stimulation for RANCT05003310 · 2021-10-19
RECRUITINGTreatment of Acute Mood Depressive Episode in Borderline Personality Disorder With rTMSNCT04870255 · 2021-07-20
RECRUITINGGamma Light and Sound Stimulation in SchizophreniaNCT07342465 · 2026-12-01
NOT_YET_RECRUITINGFeasibility of Noninvasive Trigeminal Nerve Stimulation During ExerciseNCT07686302 · 2026-10-01
NOT_YET_RECRUITINGHome-Based Wearable rTMS Therapy for Moderate to Severe DepressionNCT07775586 · 2026-08-20
NOT_YET_RECRUITINGAuditory Stimulation for Insomnia and DepressionNCT07553364 · 2026-08-01
WITHDRAWNEfficacy and Safety of a Theta Burst Stimulation Protocol of Repetitive Transcranial Magnetic Stimulation in Treatment-Resistant DepressionNCT07529574 · 2026-05-01
NOT_YET_RECRUITINGEffects of Transcutaneous Auricular Vagus Nerve Stimulation on AppetiteNCT07444177 · 2026-01-12
COMPLETEDEfficacy and Safety of Temporal Interference Stimulation on Cognitive Function in Patients With Early-Stage Alzheimer's DiseaseNCT07543094 · 2025-11-01
ENROLLING_BY_INVITATIONEffect of Transcutaneous Auricular Electroacupuncture on Sleep Disturbances in Patients With Rheumatoid Arthritis: A Randomized Double-Blind Clinical TrialNCT06527547 · 2024-06-06
UNKNOWNTBS Treatment for Treatment-Resistant DepressionNCT05388539 · 2022-06-06
COMPLETEDRapid Acting TMS for Suicide Ideation in DepressionNCT05100004 · 2021-11-07
WITHDRAWNRestoration of Cognitive Function With TDCS and Training in Serious Mental IllnessNCT03208036 · 2018-07-15
COMPLETEDtaVNS in Mild to Moderate Parkinson's DiseaseNCT04157621 · 2018-03-20
COMPLETEDAdaptive Design Study of NEST sTMS in Subjects With Major Depressive DisorderNCT03288714 · 2017-11-27
COMPLETEDTranscranial Direct Current Stimulation for Depression in Alzheimer's Disease Patient - Preliminary ResearchNCT02351388 · 2014-12-01
TERMINATEDEffects of Transvenous Vagus Nerve Stimulation on Immune Response: a Pilot StudyNCT01944228 · 2013-08-01
COMPLETEDCommon conditions
Depressive Disorder, Major3Major Depressive Disorder3Alzheimer Disease2Depression2Depression - Major Depressive Disorder2Rheumatoid Arthritis2Appetite Regulation1Bipolar Disorder1Borderline Personality Disorder1COPD1Depressive Disorder1Depressive Episode1Eating Behaviour1Food Intake1Inflammation1Insomnia1Major Depressive Disorder (MDD)1Obesity1Parkinson Disease1Schizo Affective Disorder1Schizophrenia1Schizophrenia Spectrum Disorders1Sleep Quality1Suicide1Transcutaneous Electric Nerve Stimulation1
Leading sponsors
Stanford University2Galvani Bioelectronics1Johns Hopkins University1Juan Jiao1Jung-Sun Lee1Massachusetts Institute of Technology1Medical University of South Carolina1Medtronic Cardiac Rhythm and Heart Failure1National Center of Neurology and Psychiatry, Japan1Ruijin Hospital1Seoul National University Hospital1Shanghai Mental Health Center1University of Sao Paulo1VA Office of Research and Development1Wake Forest University Health Sciences1
Trial status mix
COMPLETED6
NOT_YET_RECRUITING4
RECRUITING2
WITHDRAWN2
ENROLLING_BY_INVITATION1
TERMINATED1
UNKNOWN1
Phase mix
NA16
PHASE11
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.